Randall Lutter

With over 25 years senior experience in the analysis and management of federal programs to protect health, safety, and the environment, Dr. Lutter brings substantial expertise in high-level strategy and economic analysis to PNG.

Dr. Lutter recently served until October as Senior Science and Regulatory Advisor in the Office of the Commissioner of the U.S. FDA, where he has led projects involving competition in pharmaceutical markets and drug pricing, the regulation of tobacco products, and the surveillance of medical product supply chains disrupted by COVID-19. He also served at FDA from 2003 to 2009 as Chief Economist and later as Deputy Commissioner for Policy, leading new policy development for genetically engineered animals, animal clones, prevention of mad cow disease and updating user fee programs for drugs and devices. Dr. Lutter also worked as senior economist in the Office of Information and Regulatory Affairs (OIRA) in Office of Management and Budget (OMB) and the President’s Council of Economic Advisers.

Dr. Lutter earned a doctorate in economics at Cornell University, Dr. Lutter also boasts an extensive resume within academia, including faculty positions at the State University of New York at Buffalo and the Frank Batten School of Leadership and Public Policy at University of Virginia. He was also a visiting fellow at Resources for the Future, resident scholar at the American Enterprise Institute (AEI), and a fellow at the AEI-Brookings Joint Center for Regulatory Studies.